These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35399937)

  • 41. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study on the relationship between DNA methylation of target CpG sites in peripheral blood and gestational diabetes during early pregnancy.
    Wang X; Huang J; Zheng Y; Long S; Lin H; Zhang N; Tian M; Wu X; An R; Ma S; Tan H
    Sci Rep; 2021 Oct; 11(1):20455. PubMed ID: 34650136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study.
    Qie R; Chen Q; Wang T; Chen X; Wang J; Cheng R; Lin J; Zhao Y; Liu D; Qin P; Cheng C; Liu L; Li Q; Guo C; Zhou Q; Tian G; Han M; Huang S; Zhang Y; Wu X; Wu Y; Li Y; Yang X; Zhao Y; Feng Y; Hu D; Zhang M
    J Hum Genet; 2021 Apr; 66(4):347-357. PubMed ID: 32968204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whole Genomic DNA Methylation Profiling of CpG Sites in Promoter Regions of Dorsal Root Ganglion in Diabetic Neuropathic Pain Mice.
    Chen W; Lan T; Sun Q; Zhang Y; Shen D; Hu T; Liu J; Chong Y; Wang P; Li Q; Cui W; Yang F
    J Mol Neurosci; 2021 Dec; 71(12):2558-2565. PubMed ID: 33950354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
    Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
    Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.
    Han F; Sun LP; Liu S; Xu Q; Liang QY; Zhang Z; Cao HC; Yu J; Fan DM; Nie YZ; Wu KC; Yuan Y
    Oncotarget; 2016 Apr; 7(17):24800-9. PubMed ID: 27050149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential methylation of genes in individuals exposed to maternal diabetes in utero.
    Chen P; Piaggi P; Traurig M; Bogardus C; Knowler WC; Baier LJ; Hanson RL
    Diabetologia; 2017 Apr; 60(4):645-655. PubMed ID: 28127622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A preliminary study showing no association between methylation levels of C3 gene promoter and the risk of CAD.
    Cai G; Huang Z; Yu L; Li L
    Lipids Health Dis; 2019 Jan; 18(1):5. PubMed ID: 30611277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal corticotropin-releasing hormone is associated with LEP DNA methylation at birth and in childhood: an epigenome-wide study in Project Viva.
    Tian FY; Rifas-Shiman SL; Cardenas A; Baccarelli AA; DeMeo DL; Litonjua AA; Rich-Edwards JW; Gillman MW; Oken E; Hivert MF
    Int J Obes (Lond); 2019 Jun; 43(6):1244-1255. PubMed ID: 30464231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of methylation quantitative trait loci (mQTLs) influencing promoter DNA methylation of alcohol dependence risk genes.
    Zhang H; Wang F; Kranzler HR; Yang C; Xu H; Wang Z; Zhao H; Gelernter J
    Hum Genet; 2014 Sep; 133(9):1093-104. PubMed ID: 24889829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
    Cui J; Rohr LR; Swanson G; Speights VO; Maxwell T; Brothman AR
    Prostate; 2001 Feb; 46(3):249-56. PubMed ID: 11170154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-Adducin gene promoter DNA methylation and the risk of essential hypertension.
    Bayoumy NMK; El-Shabrawi MM; Leheta OF; Omar HH
    Clin Exp Hypertens; 2017; 39(8):764-768. PubMed ID: 28686109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Association of promoter methylation of ERp57 gene with the pathogenesis of cervical lesions in Uighur women].
    Abdula M; Abudulajiang G; Amiduo R; Abudala A; Hasim A
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):600-3. PubMed ID: 24314218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.
    Deckers IA; van Engeland M; van den Brandt PA; Van Neste L; Soetekouw PM; Aarts MJ; Baldewijns MM; Keszei AP; Schouten LJ
    Int J Epidemiol; 2017 Apr; 46(2):622-631. PubMed ID: 27789672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.
    Agha G; Mendelson MM; Ward-Caviness CK; Joehanes R; Huan T; Gondalia R; Salfati E; Brody JA; Fiorito G; Bressler J; Chen BH; Ligthart S; Guarrera S; Colicino E; Just AC; Wahl S; Gieger C; Vandiver AR; Tanaka T; Hernandez DG; Pilling LC; Singleton AB; Sacerdote C; Krogh V; Panico S; Tumino R; Li Y; Zhang G; Stewart JD; Floyd JS; Wiggins KL; Rotter JI; Multhaup M; Bakulski K; Horvath S; Tsao PS; Absher DM; Vokonas P; Hirschhorn J; Fallin MD; Liu C; Bandinelli S; Boerwinkle E; Dehghan A; Schwartz JD; Psaty BM; Feinberg AP; Hou L; Ferrucci L; Sotoodehnia N; Matullo G; Peters A; Fornage M; Assimes TL; Whitsel EA; Levy D; Baccarelli AA
    Circulation; 2019 Aug; 140(8):645-657. PubMed ID: 31424985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential DNA methylation of microRNAs within promoters, intergenic and intragenic regions of type 2 diabetic, pre-diabetic and non-diabetic individuals.
    Pheiffer C; Erasmus RT; Kengne AP; Matsha TE
    Clin Biochem; 2016 Apr; 49(6):433-438. PubMed ID: 26656639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.